About the Product

Description


Ondotyle MD Tablet is an effective medication designed to prevent nausea and vomiting caused by various factors, including chemotherapy, radiotherapy, and surgery. The active ingredient, ondansetron, is a selective serotonin 5-HT3 receptor antagonist that works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. This makes Ondotyle MD particularly useful for patients undergoing treatment that is known to induce these uncomfortable symptoms.

Each Ondotyle MD tablet contains 4 mg of ondansetron in a mouth-dissolving formulation, providing a convenient option for those who may have difficulty swallowing pills. The rapid disintegration of the tablet allows for quick absorption into the bloodstream, ensuring prompt relief from nausea and vomiting.

Common side effects may include headache, dizziness, constipation, and fatigue. In rare cases, serious allergic reactions may occur.

Ondotyle MD is indicated for the prevention of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery.

Consult your healthcare provider before use, especially if you have a history of heart conditions or are pregnant or breastfeeding. In summary, Ondotyle MD stands out for its targeted action and ease of use, making it an essential option for those needing effective management of nausea and vomiting. Always follow your healthcare provider's instructions regarding dosage and duration of treatment to ensure optimal outcomes.

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ondansetron 4mg MD (Mouth Dissolving) Tablet in the PCD pharma franchise market?

Ondansetron 4mg MD Tablet has strong demand in the gastroenterology, oncology, pediatrics, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on antiemetic and supportive care portfolios.

Why should medical distributors include Ondansetron 4mg MD Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for nausea and vomiting management under medical supervision. Ondansetron 4mg is a selective 5-HT3 receptor antagonist that helps prevent and control nausea and vomiting Commonly prescribed for gastroenteritis, drug-induced nausea, post-operative nausea and vomiting, and chemotherapy- or radiotherapy-associated nausea The mouth-dissolving (MD) formulation provides convenience for patients who have difficulty swallowing tablets or are actively nauseated Offers rapid administration without the need for water Widely used by gastroenterologists, pediatricians, oncologists, surgeons, and general physicians This strengthens a comprehensive gastroenterology and supportive care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron 4mg MD Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand across multiple specialties, repeat orders from hospitals and clinics, year-round usage, reliable supply chain support, and attractive margins in the antiemetic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.